Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease

References

• Andres, PG, Friedman, LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:255–81, vii.
   PubMed Web of Science ®Google Scholar
• Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182–205
   PubMed Web of Science ®Google Scholar
• Watts DA, Satsangi J. The genetic jigsaw of inflammatory bowel disease. Gut 2002; 50 Suppl 3: III31–6
   PubMedGoogle Scholar
• Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease–common variant or not?. Hum Mol Genet 2002; 11: 2417–23
   PubMed Web of Science ®Google Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 May 31; 411: 599–603
   PubMed Web of Science ®Google Scholar
• Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603–6
   PubMed Web of Science ®Google Scholar
• Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 521–36
   PubMed Web of Science ®Google Scholar
• Ho GT, Moodie FM, Satsangi J. Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease?. Gut 2003; 52: 759–66
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–98
   PubMed Web of Science ®Google Scholar
• Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998; 161: 5733–44
   PubMed Web of Science ®Google Scholar
• Langmann T, Moehle C, Mauerer R, Scharl M, Liebisch G, Zahn A, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004; 127: 26–40
   PubMed Web of Science ®Google Scholar
• Schaeffeler E, Eichelbaum M, Brinkmann U, Penger A, Asante-Poku S, Zanger UM, et al. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet 2001; 358: 383–4
   PubMed Web of Science ®Google Scholar
• Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, et al. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001; 69: 169–74
   PubMed Web of Science ®Google Scholar
• Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 2003; 73: 1282–92
   PubMed Web of Science ®Google Scholar
• Croucher PJ, Mascheretti S, Foelsch UR, Hampe J, Schreiber S. Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology 2003; 125: 1919–20
   PubMed Web of Science ®Google Scholar
• Gazouli M, Zacharatos P, Gorgoulis V, Mantzaris G, Papalambros E, Ikonomopoulos J. The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcerative colitis in a Greek population. Gastroenterology 2004; 126: 367–9
   PubMed Web of Science ®Google Scholar
• Glas J, Torok HP, Schiemann U, Folwaczny C. MDR1 gene polymorphism in ulcerative colitis. Gastroenterology 2004; 126: 367
   PubMedGoogle Scholar
• Potočnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun 2004; 5: 530–9
   PubMed Web of Science ®Google Scholar
• Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003; 124: 26–33
   PubMed Web of Science ®Google Scholar
• Nolte IM, te Meerman GJ. The probability that similar haplotypes are identical by descent. Ann Hum Genet 2002; 66: 195–209
   PubMedGoogle Scholar
• Oostenbrug LE, Drenth JP, de Jong DJ, Nolte IM, Oosterom E, van Dullemen HM, et al. Association between toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005; 11: 567–75
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; Suppl 170: 2–6
   Web of Science ®Google Scholar
• Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347: 417–29
   PubMed Web of Science ®Google Scholar
• Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6: 8–15
   PubMed Web of Science ®Google Scholar
• Nolte, IM, Spijker, GT, Boon, M, Jansen, RC, Postma, DS, Buys, CHCM, , et al. The haplotype sharing statistic: fine-mapping of disease gene loci by comparing patients and controls for the length of haplotype sharing. [Thesis] Groningen, The Netherlands: IM Nolte, 2002.
   Google Scholar
• Beckmann L, Fischer C, Deck KG, Nolte IM, te Meerman G, Chang-Claude J. Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet Epidemiol 2001; 21 Suppl 1: S554–9
   Google Scholar
• Boon M, Nolte IM, Bruinenberg M, Spijker GT, Terpstra P, Raelson J, et al. Mapping of a susceptibility gene for multiple sclerosis to the 51 kb interval between G511525 and D6S1666 using a new method of haplotype sharing analysis. Neurogenetics 2001; 3: 221–30
   PubMedGoogle Scholar
• de Jong MM, Nolte IM, de Vries EG, Schaapveld M, Kleibeuker JH, Oosterom E, et al. The HLA class III subregion is responsible for an increased breast cancer risk. Hum Mol Genet 2003; 12: 2311–9
   PubMedGoogle Scholar
• Levinson DF, Kirby A, Slepner S, Nolte I, Spijker GT, te Meerman GJ. Simulation studies of detection of a complex disease in a partially isolated population. Am J Med Genet 2001; 105: 65–70
   PubMedGoogle Scholar
• Lewontin R. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49–67
   PubMed Web of Science ®Google Scholar
• Ho GT, Nimmo ER, Tenesa A, Fennell J, Drummond H, Mowat C, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology 2005; 128: 288–96
   PubMed Web of Science ®Google Scholar
• Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473–8
   PubMed Web of Science ®Google Scholar
• Colhoun HM, McKeigue PM, Davey SG. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865–72
   PubMed Web of Science ®Google Scholar